- Associated Press - Wednesday, December 29, 2010

GAITHERSBURG, Md. (AP) — GenVec Inc., a biotechnology company, said Wednesday it agreed to work with Merial, a producer of vaccine for foot-and-mouth disease, to develop and commercialize its own technology for a foot-and-mouth disease vaccine.

Under the deal, Merial, the animal health unit of French pharmaceutical group Sanofi-Aventis, will be responsible for all costs related to developing and commercializing foot-and-mouth disease vaccines through the agreement.

GenVec will receive development milestones and royalties on sales.

GenVec’s vaccine approach is developed without using live or killed virus materials so it can be produced cost effectively, GenVec said.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide